Jamia Hamdard

How is Jamia Hamdard ranked in 2026?

Jamia Hamdard's headline achievement is its NIRF Pharmacy Rank #1 (2025) with a score of 86.59, making the New Delhi deemed university the best pharmacy institution in India for the second consecutive year. Beyond pharmacy, Jamia Hamdard holds NIRF Medical Rank #40 (2025), NIRF University Rank #47 (2025), NIRF Overall Rank #74 (2025) and NIRF Management Rank #87 (2025). Internationally, it is placed at QS World University Rankings Asia #498 (2026), QS World Overall #1401 (2026) and Times Higher Education (THE) World Overall #801 (2026). In short, Jamia Hamdard is a pharmacy-led institution that ranks at the very top of its core discipline nationally while sitting in the mid-tier of broad national and global league tables.

This combination tells an applicant exactly what Jamia Hamdard is: a specialist health-sciences university whose pharmacy and medical programmes punch far above the institution's overall position. The #1 pharmacy rank is not a one-off; Jamia Hamdard topped the NIRF Pharmacy category in 2021 and 2022, slipped to #2 in 2023, then reclaimed #1 in both 2024 and 2025.

Year-Wise Rankings

The table below consolidates Jamia Hamdard's verified ranks across the major Indian (NIRF) and global (QS, THE) frameworks for 2024, 2025 and 2026. It answers the core question an aspirant asks: how does this university rank category by category, and is the number moving up or down? Read it by tracking each ranking body and category down its rows. Scores are shown where the framework publishes them; NIRF reports a 0-100 score for its top-ranked institutions.

The pattern is clear: pharmacy is the engine. Jamia Hamdard's pharmacy score actually rose from 84.01 in 2024 to 86.59 in 2025 even as its broad-based positions softened. Medical improved (44 to 40), while University (40 to 47), Overall (62 to 74) and Management (78 to 87) all slipped by 7 to 12 places in 2025. For an applicant, the message is that a pharmacy or medical aspirant gets a top-tier institution, whereas a management aspirant should weigh the #87 position carefully.

Ranking Trajectory of Jamia Hamdard

Jamia Hamdard's trajectory is a story of a strengthening specialism inside a broadening institution that is being out-competed on the general tables. In NIRF Pharmacy it climbed back from #2 in 2023 to #1 in 2024 and defended that crown in 2025, with its score improving year on year (84.01 to 86.59). That is the single most important trend for a prospective pharmacy student: the university is not just holding rank one, it is widening its scoring lead.

The broad-based categories moved the other way in 2025. The Overall rank fell from #62 (2024) to #74 (2025), a drop of 12 places, and the University rank eased from #40 to #47. Reporting noted that Jamia Hamdard, alongside Jamia Millia Islamia and AMU, slid in the 2025 NIRF tables. Medical bucked the trend, improving from #44 (2024) to #40 (2025). On the global side, QS Asia momentum is positive: Jamia Hamdard moved from the 501-520 band in 2025 to a precise #498 in 2026, climbing roughly three places and crossing into the top 500 of Asia for the first time. It also features in QS World Overall at #1401 and THE World Overall at #801 for 2026.

How Jamia Hamdard Compares

In pharmacy, Jamia Hamdard sits at the very top of the national peer set. The following comparison places it against the institutions immediately around it in the NIRF Pharmacy 2025 ranking, answering the question "who does Jamia Hamdard beat, and who is closest behind it?" Read each row as a direct competitor; Jamia Hamdard's score of 86.59 is the reference benchmark.

The takeaway is decisive for pharmacy aspirants: Jamia Hamdard out-ranks heavyweight names such as BITS Pilani and NIPER Hyderabad in the NIRF Pharmacy 2025 list, having reclaimed the top spot from NIPER Hyderabad in 2024. The contrast with its own general standing is the key insight: a university ranked #74 overall is simultaneously the undisputed #1 in pharmacy, which is exactly why discipline-specific ranking matters more than the headline overall number when choosing Jamia Hamdard.

For context on outcomes that sit behind these ranks, NIRF 2025 data shows Jamia Hamdard's median packages of around Rs 3.25 LPA for 3-year UG, Rs 5.10 LPA for 4-year UG and Rs 7.80 LPA for 5-year UG programmes, with PG medians near Rs 6.10 LPA (2-year) and Rs 9.35 LPA (3-year). The flagship 4-year B.Pharm, with 60 seats, carries a total tuition of about Rs 6,40,000, and a reported highest UG package of around Rs 31 lakh (Deloitte). These figures help explain why the pharmacy and medical verticals anchor the university's ranking strength.